Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1994-1-10
|
pubmed:abstractText |
We have reported that 19-hydroxyandrostenedione (19-OH-A-dione) functions as an amplifier of the sodium-retaining and hypertensive action of aldosterone. We therefore measured 19-hydroxyandrostenedione in hypertensive patients.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0300-0664
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
39
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
557-60
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8252745-Adult,
pubmed-meshheading:8252745-Androstenedione,
pubmed-meshheading:8252745-Humans,
pubmed-meshheading:8252745-Hypertension,
pubmed-meshheading:8252745-Male,
pubmed-meshheading:8252745-Middle Aged,
pubmed-meshheading:8252745-Radioimmunoassay,
pubmed-meshheading:8252745-Renin
|
pubmed:year |
1993
|
pubmed:articleTitle |
Plasma 19-hydroxyandrostenedione is elevated in patients with high renin essential hypertension.
|
pubmed:affiliation |
Third Department of Internal Medicine, University of Tokyo Faculty of Medicine, Japan.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|